Search research articles
Contact Us
Filters
Showing results (81-90 of 99) with videos related to
Page
of 10
Sort By:
Hepatology (Baltimore, Md.)
|
March 31, 2023
Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers
Changhoon Yoo, Milind M Javle, Helena Verdaguer Mata, et al.
Cancer Medicine
|
July 12, 2021
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients
Chirayu Mohindroo, Merve Hasanov, Jane E Rogers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients
J Castillo, V Bernard, F A San Lucas, et al.
Plos One
|
June 24, 2016
Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer
Awalpreet S Chadha, Heath D Skinner, Jillian R Gunther, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2026
A Phase 2 Trial of an Extended-release siRNA Implant Targeting KRAS G12D/V in Locally Advanced Pancreatic Cancer
Brinda Alagesan, Anna M Varghese, Celina Ang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2024
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
Rachna T Shroff, Gentry King, Sarah Colby, et al.
The Oncologist
|
February 1, 2024
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors
Sarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 3, 2019
Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma
Awalpreet S Chadha, Jillian R Gunther, Cheng-En Hsieh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer
Thatcher Ross Heumann, Jiayun Lu, Hao Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2015
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Theodore S Hong, Jennifer Y Wo, Beow Y Yeap, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 99) with videos related to
Sort By:
Page
of 10
Hepatology (Baltimore, Md.)
|
March 31, 2023
Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers
Changhoon Yoo, Milind M Javle, Helena Verdaguer Mata, et al.
Cancer Medicine
|
July 12, 2021
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients
Chirayu Mohindroo, Merve Hasanov, Jane E Rogers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients
J Castillo, V Bernard, F A San Lucas, et al.
Plos One
|
June 24, 2016
Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer
Awalpreet S Chadha, Heath D Skinner, Jillian R Gunther, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2026
A Phase 2 Trial of an Extended-release siRNA Implant Targeting KRAS G12D/V in Locally Advanced Pancreatic Cancer
Brinda Alagesan, Anna M Varghese, Celina Ang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2024
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
Rachna T Shroff, Gentry King, Sarah Colby, et al.
The Oncologist
|
February 1, 2024
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors
Sarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
April 3, 2019
Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma
Awalpreet S Chadha, Jillian R Gunther, Cheng-En Hsieh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer
Thatcher Ross Heumann, Jiayun Lu, Hao Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 16, 2015
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Theodore S Hong, Jennifer Y Wo, Beow Y Yeap, et al.
Page
of 10